Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

Okairos

Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.

Acquired by GSK (GlaxoSmithKline) on May 29, 2013

Website: https://www.okairos.com

Founded: January 01, 2007

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Genetica	Healthcare Equipment & Services	Leading Gene Decoding In Asia - Genetica provides low-cost, direct-to-consumer, ge ...
Vivodyne	Healthcare Equipment & Services	Discovers life-changing drugs and cellular therapies - Vivodyne accelerates the discovery of cures to hum ...

View more competitors»

Date	Round	Amount	Investors
Sep 14, 2010	Series B	$ 20,500,000	Versant Ventures Boehringer Ingelheim Venture Fund
Mar 19, 2007	Series A	€ 7,200,000	BioMedPartners Novartis Venture Fund Life Sciences Partners

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.